Oxford Heartbeat Ltd.

Oxford Heartbeat Ltd. is a United Kingdom medical software company based in London. It develops decision-support software for clinicians, with its flagship product being PreSize® Neurovascular. According to the company's official website, PreSize® Neurovascular is a decision-support medical software tool that helps clinicians plan and perform neurovascular surgeries involving implant devices in real time. The software allows users to import routine patient scans, automatically build a virtual patient-specific blood vessel model, position digital twins of different implants into that model, and generate a best-fit device recommendation based on the patient's specific anatomy. Clinicians can then make further adjustments and rehearse different surgical scenarios before the actual procedure. The company positions its technology around improving surgical decision-making and patient outcomes. Its stated mission is to provide clinicians with powerful technology to make life-saving decisions and offer every patient the highest standards of care. Its stated vision is a world where successful surgery is the norm rather than the exception. The official website highlights several performance claims, including 96% highest validated accuracy in device deployment simulation, a three-minute real-time case rehearsal time on PreSize®, and selection of devices 4 mm shorter using PreSize® compared with procedures without it. It also notes that 10 UK hospitals are participating in the PreSize® Neurovascular clinical impact trial, with more expected to join. Oxford Heartbeat operates in the medical technology and surgical planning software space, specifically focused on neurovascular interventions. Its product is intended to support clinicians in selecting the best-fit implant device before surgery, aiming to reduce surgical complications and improve patient outcomes. The company has received media attention, including being featured on BBC Click, as noted on its website. It also actively recruits, inviting driven individuals to join its team of innovators. As a private company, Oxford Heartbeat Ltd. is not publicly listed. Its headquarters is in London, United Kingdom, and its primary market is the UK, with potential international application for its medical software. The company's core offering is PreSize® Neurovascular, a surgery planning software platform. Its activities center on software development, clinical validation, and hospital partnerships for neurovascular surgical planning.

Oxford Heartbeat Ltd. is a London-based medical software company. Publicly available information about its founding year and founders is limited in the supplied evidence. The company is known for developing PreSize® Neurovascular, a decision-support software platform for neurovascular surgery planning. According to its official website, the software allows clinicians to import routine patient scans, automatically build a virtual patient-specific blood vessel model, position digital twins of different implants into the model, and generate a best-fit device recommendation. Clinicians can rehearse cases in real time and try different surgical scenarios before the actual procedure. The company's stated mission is to provide clinicians with powerful technology to make life-saving decisions and offer every patient the highest standards of care. Its vision is a world where successful surgery is the norm, not the exception. The website highlights performance metrics such as 96% highest validated accuracy in device deployment simulation, 3 minutes to rehearse a case on PreSize® in real time, and 4 mm shorter devices selected using PreSize® compared with procedures without it. It also notes that 10 UK hospitals are participating in the PreSize® Neurovascular clinical impact trial, with more expected to join. Oxford Heartbeat has received media coverage, including being featured on BBC Click, as stated on its website. The company is headquartered in London, United Kingdom, and operates as a private entity. Its primary focus is on the UK market, with potential for broader international use of its medical software. The company continues to develop its technology and engage with hospitals for clinical validation.

AI-powered decision-support software for neurovascular surgery planning, aiming to improve device selection and patient outcomes.

• PreSize® Neurovascular

  Decision-support medical software that helps clinicians plan and perform neurovascular surgeries with implant devices in real time. Users import routine patient scans, the software automatically builds a virtual patient-specific blood vessel model, users position digital twins of different implants into the model, and the software generates a best-fit device recommendation. Users can rehearse cases and try different surgical scenarios before the actual procedure.

1. 1Oxford Heartbeat PreSize Neurovascular | Oxford Heartbeatoxfordheartbeat.com
2. 2Oxford Heartbeat Ltd. (United Kingdom) - Wikidatawikidata.org